» Articles » PMID: 38649856

25-hydroxycholesterol Promotes Proliferation and Metastasis of Lung Adenocarcinoma Cells by Regulating ERβ/TNFRSF17 Axis

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2024 Apr 22
PMID 38649856
Authors
Affiliations
Soon will be listed here.
Abstract

Lung adenocarcinoma is the main type of lung cancer in women. Our previous findings have evidenced that 25-hydroxycholesterol (25-HC) promotes migration and invasion of lung adenocarcinoma cells (LAC), during which LXR as a 25-HC receptor plays an important role. Estrogen receptor beta (ERβ) is a receptor of 27-hydroxycholesterol that is structurally analogous to 25-HC, but its role in the functional actions of 25-HC remained largely unknown. In this study, we demonstrated that 25-HC treatment triggered ERβ expression in LAC. Knockdown of ERβ inhibited 25-HC-mediated proliferation, migration and invasion, and reduced 25-HC-induced LAC metastasis in vivo. Further investigation revealed that ERβ knockdown restrained the expression of TNFRSF17 (BCMA). In vivo experiments also confirmed that ERβ knockdown blocked 25-HC-induced TNFRSF17 expression. TNFRSF17 knockdown also restrained 25-HC-induced proliferation, migration and invasion. Bioinformatic analysis showed that the levels of ERβ and TNFRSF17 were elevated in lung adenocarcinoma, and were closely related to tumor stages and nodal metastasis status. These results suggested that 25-HC promoted the proliferation and metastasis of LAC by regulating ERβ/TNFRSF17 axis.

Citing Articles

Oxidative Stress and Reprogramming of Lipid Metabolism in Cancers.

Li S, Yuan H, Li L, Li Q, Lin P, Li K Antioxidants (Basel). 2025; 14(2).

PMID: 40002387 PMC: 11851681. DOI: 10.3390/antiox14020201.


UBE2J1 is identified as a novel plasma cell-related gene involved in the prognosis of high-grade serous ovarian cancer.

Tian Y, Dong R, Guan Y, Wang Y, Zhao W, Zhang J J Transl Med. 2025; 23(1):129.

PMID: 39876019 PMC: 11776235. DOI: 10.1186/s12967-025-06135-9.


NUSAP1 is Upregulated by Estrogen to Promote Lung Adenocarcinoma Growth and Serves as a Therapeutic Target.

Zhang S, Zhang X, Huang W, Jiang G, Mo Y, Wei L Int J Biol Sci. 2024; 20(13):5375-5395.

PMID: 39430250 PMC: 11489181. DOI: 10.7150/ijbs.100188.


The MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism.

Davis J, Waltz S Genes (Basel). 2024; 15(7).

PMID: 39062731 PMC: 11275592. DOI: 10.3390/genes15070953.

References
1.
Mollerup S, Jorgensen K, Berge G, Haugen A . Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer. 2002; 37(2):153-9. DOI: 10.1016/s0169-5002(02)00039-9. View

2.
Hershberger P, Vasquez A, Kanterewicz B, Land S, Siegfried J, Nichols M . Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res. 2005; 65(4):1598-605. DOI: 10.1158/0008-5472.CAN-04-2694. View

3.
van de Donk N, Usmani S, Yong K . CAR T-cell therapy for multiple myeloma: state of the art and prospects. Lancet Haematol. 2021; 8(6):e446-e461. DOI: 10.1016/S2352-3026(21)00057-0. View

4.
Jasim S, Kzar H, Haider Hamad M, Ahmad I, Al-Gazally M, Ziyadullaev S . The emerging role of 27-hydroxycholesterol in cancer development and progression: An update. Int Immunopharmacol. 2022; 110:109074. DOI: 10.1016/j.intimp.2022.109074. View

5.
Ali G, Donati V, Loggini B, Servadio A, DellOmodarme M, Prati M . Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma. Hum Pathol. 2008; 39(10):1465-73. DOI: 10.1016/j.humpath.2008.02.011. View